References
- Sheiner BB, Beal S, Rosenberg B, et al., Forecasting individual pharmacokinetics. Clin Pharmac Ther 1979; 31: 294-9.
- Hurst A, Yoshinaga M, Mitani G, et al., Application of a bayesian method to monitor and adjust vancomycin dosage regimens. Antimicrob Agents Chemother 1990; 34: 1165-71. https://doi.org/10.1128/AAC.34.6.1165
- Touw DJ, Proost JH, Stevens R, et al., Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus. Pharm World Sci 2001; 23: 200-8. https://doi.org/10.1023/A:1012490704731
- Nielsen EI, Sandström M, Honoré PH, et al., Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clin Pharmacokinet 2009; 48: 253-9. https://doi.org/10.2165/00003088-200948040-00003
- Seaton C, Ignas J, Muchohi S, et al., Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition. J Antimicrob Chemother 2007; 59: 681-90. https://doi.org/10.1093/jac/dkl561
- García B, Barcia E, Perez F, et al., Population pharmacokinetics of gentamicin in premature newborns. J Antimicrob Chemother 2006; 58: 372-81. https://doi.org/10.1093/jac/dkl244
- Xuan D, Nicolau DP, Nightingale CH. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing. Int J Antimicrob Agents 2004; 23: 291-8. https://doi.org/10.1016/j.ijantimicag.2003.07.010
- Treluyer JM, Merlé Y, Tonnelier S, et al., Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children. Antimicrob Agents Chemother 2002; 46: 1381-8. https://doi.org/10.1128/AAC.46.5.1381-1387.2002
- Biggeri A, Marchi M, Lagazio C, et al., Non-parametric maximum likelihood estimators for disease mapping. Stat Med 2000; 15: 2539-46.
- Bustad A, Terziivanov D, Leary R, et al., Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies. Clin Pharmacokinet 2006; 45: 365- 71. https://doi.org/10.2165/00003088-200645040-00003
- Stolk LM, Degraeuwe PL, Nieman FH, et al., Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit 2002; 24: 527-33. https://doi.org/10.1097/00007691-200208000-00011
- Rougier F, Claude D, Maurin M, et al., Aminoglycoside nephrotoxicity: modeling, simulation, and control. Antimicrob Agents Chemother 2003; 47: 1010-18. https://doi.org/10.1128/AAC.47.3.1010-1016.2003
- Garrison MW, Zaske DE, Rotschafer JC. Aminoglycosides: another perspective. Ann Pharmacother 1990; 24: 267-73.
- Burm JP. The influence of weight with assay error on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patients. Biopharm. Drug Dispos 2005; 26: 189-95. https://doi.org/10.1002/bdd.450
- Jelliffe RW, D'Argenio DZ, Schumitzky A, et al., The USC*PACK PC programs for planning, monitoring and adjusting drug dosage regimens. Proceedings of the twenty-third annual meeting of the Association for the Advancement of Medical Instrumentation. Washington, DC, May 13, 1988.
- Press SJ. Bayesian statistics: Principles, models, and application. John Wiley & Sons, Inc., 1989; 175.
- Jelliffe RW, Schumitzky A. User manual for the nonparametric EM program for population pharmacokinetic modeling version 1. University of Southern California, School of Medicine, Los Angeles, Calfornia 1989.
- Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. J Pharmacokinet Biopharm 1976; 4: 183-8. https://doi.org/10.1007/BF01086153
- Vercaigne LM, Ariano RE, Zacharias JM. Bayesian pharmacokinetics of gentamicin in a haemodialysis population. Clin Pharmacokinet 2004; 43: 205-10. https://doi.org/10.2165/00003088-200443030-00004
- Jelliffe RW, Iglesias T, Hurst A, et al., Individualizing gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring stategies. Clin Pharmacokinet 1991; 21: 461-8. https://doi.org/10.2165/00003088-199121060-00006
- Erdmann SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods. Part III: amionglycoside antibiotics. Clin Pharmacokinet 1991; 20: 374-9. https://doi.org/10.2165/00003088-199120050-00003
- Thomson AH, Whiting B. Bayesian parameter estimation and population pharmacokinetics. Clin Pharmacokinet 1992; 22: 447-13. https://doi.org/10.2165/00003088-199222060-00004
- Jelliffe RW, Schumitzky A, Van Guilder M. Nonpharmacokinetic factors affecting aminoglycoside therapeutic precision: A simulation study. Drug Invest 1992; 4: 20-7. https://doi.org/10.1007/BF03258374
- Antal EJ, Grasela TH, Smith RB. An evaluation of population pharmacokinetics in therapeutic trials. Part III: prospective data collection versus retrospective data assembly. Clin Pharmacol Ther 1989; 46: 552-8. https://doi.org/10.1038/clpt.1989.185
- Gan SH, Ismail R, Wan Adnan WA, et al., Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms. J Clin Pharm Ther 2004; 29: 455- 60. https://doi.org/10.1111/j.1365-2710.2004.00590.x
- Beal S. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. Drug Metab Rev 1984; 16: 173-9.
- Beal S. Asymptotic properties of optimization estimates for the independent net identically distributed case with application to extended least-squares estimate. Technical report of the Division of Clinical Pharmacology. University of Califormia, San Francisco 1984.
- Mallet A. A maximum likelihood estimation method for random coefficient regression models. Biometrika 1986; 73: 645-10. https://doi.org/10.1093/biomet/73.3.645
- Mallet A, Mentre F, Steimer JL, et al., Nonparametric maxmum likelihood estimation for population pharmacokinetics with application to cyclosporine. J Pharmacokinet Biopharm 1988; 16: 311-8. https://doi.org/10.1007/BF01062140
- Dodge WF, Jelliffe RW, Richardson CJ, et al., Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method. Clin Pharmacol Ther 1991; 50: 25-30. https://doi.org/10.1038/clpt.1991.100
- Bond WS. Ethnicity and psychotropic drugs. Clin Pharm 1991; 10: 467-72.
- Wood A, Zhou H. Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet 1991; 20: 350-6. https://doi.org/10.2165/00003088-199120050-00002
- Jhee SS, Burm JP, Gill MA. Comparison of aminoglycoside pharmacokinetics in asian hispanic and caucasian patient using population pharmacokinetic methods. Antimicrob Agents Chemother 1994; 38: 2073-8. https://doi.org/10.1128/AAC.38.9.2073
- Botha JH, du Preez MJ, Adhikari M. Population pharmacokinetics of gentamicin in South African newborns. Eur J Clin Pharmacol 2003; 59: 755-60. https://doi.org/10.1007/s00228-003-0663-6